Sen. Alan Armstrong bought Elevance Health (ELV)
Sen. Alan Armstrong (R-OK) · $1K–$15K · traded Mar 27, 2026
Why this is a committee overlap
Armstrong is a member of the Senate Committee on Health, Education, Labor, and Pensions, which oversees the Healthcare sector. Elevance Health is classified in the Medical - Healthcare Plans industry.
An overlap is a fact about the trade, not evidence of wrongdoing. Committee assignments are current ones.
- Transaction
- Bought
- Amount
- $1K–$15K
- Owner
- The member
- Traded
- Mar 27, 2026
- Disclosed
- Jul 21, 2026
- Days to disclose
- 116 (after the 45-day deadline)
- Asset type
- Stock
- As filed
- Elevance Health, Inc. Common Stock
- Industry
- Medical - Healthcare Plans · Healthcare
Other trades in this filing
All of Armstrong's trades →- Jul 21, 2026$5M–$25M
Sold (partial) The Williams Companies WMB
$5M–$25M · Traded Jun 24, 2026 · disclosed Jul 21, 2026 · Joint
- Jul 21, 2026$250K–$500K
Sold (full) The Williams Companies WMB
$250K–$500K · Traded Jun 22, 2026 · disclosed Jul 21, 2026 · Joint
- Jul 21, 2026$1K–$15K
Bought Air Liquide ADR France (AIQUY)
$1K–$15K · Traded Mar 31, 2026 · disclosed Jul 21, 2026 · filed 112 days later
- Jul 21, 2026$1K–$15K
$1K–$15K · Traded Mar 31, 2026 · disclosed Jul 21, 2026 · filed 112 days later
- Jul 21, 2026$1K–$15K
$1K–$15K · Traded Mar 31, 2026 · disclosed Jul 21, 2026 · filed 112 days later
Committee overlap: HELP - Jul 21, 2026$1K–$15K
$1K–$15K · Traded Mar 31, 2026 · disclosed Jul 21, 2026 · filed 112 days later
- Jul 21, 2026$1K–$15K
Bought BHP Group Limited (BHP)
$1K–$15K · Traded Mar 31, 2026 · disclosed Jul 21, 2026 · filed 112 days later
- Jul 21, 2026$1K–$15K
Bought Carrefour SA Sponsored ADR (CRRFY)
$1K–$15K · Traded Mar 31, 2026 · disclosed Jul 21, 2026 · filed 112 days later
- Jul 21, 2026$1K–$15K
Bought Compagnie Financiere Richemont AG ADR (CFRUY)
$1K–$15K · Traded Mar 31, 2026 · disclosed Jul 21, 2026 · filed 112 days later
- Jul 21, 2026$1K–$15K
$1K–$15K · Traded Mar 31, 2026 · disclosed Jul 21, 2026 · filed 112 days later
- Jul 21, 2026$1K–$15K
Bought Glencore plc Unsponsored ADR (GLNCY)
$1K–$15K · Traded Mar 31, 2026 · disclosed Jul 21, 2026 · filed 112 days later
- Jul 21, 2026$1K–$15K
Bought Heineken NV Sponsored ADR (HEINY)
$1K–$15K · Traded Mar 31, 2026 · disclosed Jul 21, 2026 · filed 112 days later
- Jul 21, 2026$1K–$15K
Bought Henkel AG & Co KGAA Sponsored ADR (HENKY)
$1K–$15K · Traded Mar 31, 2026 · disclosed Jul 21, 2026 · filed 112 days later
- Jul 21, 2026$1K–$15K
$1K–$15K · Traded Mar 31, 2026 · disclosed Jul 21, 2026 · filed 112 days later
Committee overlap: HELP - Jul 21, 2026$1K–$15K
Bought Rolls Royce Holdings plc Sponsored ADR (RYCEY)
$1K–$15K · Traded Mar 31, 2026 · disclosed Jul 21, 2026 · filed 112 days later
- Jul 21, 2026$1K–$15K
Bought Royal KPN N.V. Sponsored ADR (KKPNY)
$1K–$15K · Traded Mar 31, 2026 · disclosed Jul 21, 2026 · filed 112 days later
- Jul 21, 2026$1K–$15K
Bought SAP SE Sponsored ADR (SAP)
$1K–$15K · Traded Mar 31, 2026 · disclosed Jul 21, 2026 · filed 112 days later
- Jul 21, 2026$1K–$15K
Bought Schneider Electric SE Unsponsored ADR (SBGSY)
$1K–$15K · Traded Mar 31, 2026 · disclosed Jul 21, 2026 · filed 112 days later
- Jul 21, 2026$1K–$15K
Bought Swisscom AG Sponsored ADR (SCMWY)
$1K–$15K · Traded Mar 31, 2026 · disclosed Jul 21, 2026 · filed 112 days later
- Jul 21, 2026$1K–$15K
Bought Unicredit SPA Unsponsored ADR (UNCRY)
$1K–$15K · Traded Mar 31, 2026 · disclosed Jul 21, 2026 · filed 112 days later
Recent Congress trades in ELV
- Feb 6, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Jan 29, 2026 · disclosed Feb 6, 2026 · Spouse
- Jan 16, 2026$15K–$50K
Sen. Markwayne Mullin (R-OK)
$15K–$50K · Traded Dec 29, 2025 · disclosed Jan 16, 2026 · Joint
- Sep 12, 2025$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Aug 26, 2025 · disclosed Sep 12, 2025 · Dependent
- Sep 12, 2025$1K–$15K
Rep. Lisa C. McClain (R-MI-9)
$1K–$15K · Traded Aug 13, 2025 · disclosed Sep 12, 2025 · Spouse
- Sep 12, 2025$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
$1K–$15K · Traded Aug 5, 2025 · disclosed Sep 12, 2025
- Sep 12, 2025$1K–$15K
Rep. Val T. Hoyle (D-OR-4)
$1K–$15K · Traded Jan 13, 2025 · disclosed Sep 12, 2025 · Spouse · filed 242 days later
- Sep 12, 2025$1K–$15K
Rep. Val T. Hoyle (D-OR-4)
$1K–$15K · Traded Oct 29, 2024 · disclosed Sep 12, 2025 · Spouse · filed 318 days later
- Aug 13, 2025$1K–$15K
Rep. Lisa C. McClain (R-MI-9)
$1K–$15K · Traded Jul 10, 2025 · disclosed Aug 13, 2025 · Spouse
Company context for ELV
Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.
ELV: third_quarter 2026 lobbying report
Issues related to Pharmacy Benefit Managers, Medicare Advantage, and health insurance. Issues surrounding risk adjustment. Issues related to Pharmacy Benefit Managers, Medicare Advantage, and health insurance. Issues relating to extension of Enhanced Advanced Premium Tax Credits (EAPTCs) Issues related to No Surprises Act implementation.
Public: Oct 20, 2026, 3:32 PM EDTOriginal source ↗ELV: third_quarter 2026 lobbying report
Veterans Assuring Critical Care Expansions to Support Servicemembers (ACCESS) Act of 2025 (S. 275 and H.R. 7040) ACA Exchanges & Enrollment Enhanced Premium Tax Credits Prior Authorization Mental Health Parity Facilitating Accountability in Reimbursements Act (FAIR Act) (118th Congress) Site-based Invoicing and Transparency Enhancement (SITE) Act (118th Congress) Health Care Price Certainty for All Americans Act (H.R. 9645) AI Use in Healthcare Health Disparities, including Maternal Health and Rural Health Veterans Affairs Community Cares program The Take Care of Americas Veterans Act (H.R. 92
Public: Oct 20, 2026, 2:52 PM EDTOriginal source ↗ELV: third_quarter 2026 lobbying report
Federal budget issues Lobbying related to health care access, Medicare, and Medicaid policy Lobbying related to health care access Tax policy Lobbying related to health care access, Medicare, and Medicaid policy
Public: Oct 20, 2026, 2:24 PM EDTOriginal source ↗
From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.